Dahina generic name is nilotinib, slow grain eat 7 years nilotinib now whether to stop the drug needs to be based on the patient’s BCR/ABL gene quantification decision. Clinically nilotinib belongs to the BCR-ABL kinase inhibitors, binding and stabilizing the inactive conformation of the ABL protein kinase site. It is mainly used in the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia and chronic myeloid leukemia in children over 2 years of age. Usually the drug needs to be taken for a long period of time as prescribed by the doctor, and if the drug is stopped suddenly it may lead to worsening of the disease or complication of other symptoms. It is recommended that you consult your doctor before stopping the medication, and the decision should be made after a comprehensive assessment of your condition. Usually, Nilotinib may cause headache, nausea, fatigue, hair loss, muscle pain and other discomforts after taking the drug. It is contraindicated for those who are allergic to the components of the drug, with hypokalemia, hypomagnesemia. In the process of taking the drug, it is necessary to pay attention to myelosuppression, fluid retention and so on. And women of childbearing age, pregnant women, breastfeeding women need to use the drug under medical supervision. If you need to stop taking the drug after long-term treatment with Nilotinib, it is recommended to decide after a comprehensive assessment by a doctor.